Review and publication


An abstract is eligible for review when:

  • The abstract is submitted according to the guidelines and on or before the deadline (5 April 2018).
  • The presenting author has registered and paid (if applicable) for the congress within ten days after submitting the abstract (before 15 April 2018).

The abstracts submitted will be reviewed for:  

  • Presentation at the congress by means of a poster and/or e-poster 
  • Publication (after the congress) in the congress supplement to the journal European Neuropsychopharmacology

All submitted abstracts (from registered presenting authors) will be evaluated by a scientific review committee. Authors will be informed of the committee’s decision by e-mail before 1 July 2018 at the latest. ECNP will not enter into discussion about the outcome.

Abstracts will be available via our online scientific programme on this website and on the ECNP app in September 2018.

Conditions for publication

Abstracts accepted for publication will be published after the congress in a congress supplement to the journal European Neuropsychopharmacology only if:
  • The presenting author attends the congress
  • The poster is displayed in the poster area on the day of the poster presentation
  • The presenting author presents the poster on the day and time on which the presentation has been scheduled (please note that we will check on site to make sure people stick to their presenting schedule)​.

Important: If the presenting author does not meet all three criteria mentioned above, the abstract will not be published in the congress supplement to the journal European Neuropsychopharmacology.

The publisher of European Neuropsychopharmacology holds all publication rights including copyright.